Month: January 2021

Laurent Audoly, PhD, President and CEO of Parthenon Therapeutics, as non executive director of Ermium Therapeutics

Laurent Audoly is a pharma and biotech entrepreneur and senior executive. He is co-founder, CEO and Chairman of Parthenon Therapeutics, and has also led corporate and R&D functions across both pharma and biotech in the US and Europe, particularly in the field of auto-immune diseases, including as CEO of Kymera Therapeutics and Head of R&D at Pierre Fabre Pharmaceuticals, as well as scientific and business leadership positions at Pfizer, Merck and Pieris.